메뉴 건너뛰기




Volumn 107, Issue 4, 2012, Pages 522-530

Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: The Japan-based TWICE study

(107)  Kinoshita, Yoshikazu a   Hongo, Michio b   Mitsui, Shinya c   Hagiwara, Takeshi d   Kobayashi, Takeaki e   Karasawa, Gakuyo f   Yoshida, Yukinari g   Tominaga, Gen h   Komatsu, Masafumi i   Oizumi, Harufumi j   Igarashi, Tadayuki k   Kamoshida, Toshiro l   Masuyama, Hironori m   Kusano, Motoyasu n   Kawamura, Osamu n   Shimoyama, Yasuyuki n   Watanabe, Kazuyoshi o   Matsukura, Akira p   Takamori, Akitaka p   Hamashima, Hideki p   more..


Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PLACEBO; RABEPRAZOLE;

EID: 84862777542     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.19     Document Type: Article
Times cited : (59)

References (25)
  • 1
    • 0037258487 scopus 로고    scopus 로고
    • Epidemiology of reflux disease and CLE in East Asia
    • Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003;38 (Suppl):25-30. (Pubitemid 36442881)
    • (2003) Journal of Gastroenterology , vol.38 , Issue.SUPPL. 15 , pp. 25-30
    • Hongo, M.1    Shoji, T.2
  • 3
    • 0035102333 scopus 로고    scopus 로고
    • Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly
    • DOI 10.1046/j.1440-1746.2001.02408.x
    • Amano K, Adachi K, Katsube T et al. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol 2001;16:132-6. (Pubitemid 32226183)
    • (2001) Journal of Gastroenterology and Hepatology , vol.16 , Issue.2 , pp. 132-136
    • Amano, K.1    Adachi, K.2    Katsube, T.3    Watanabe, M.4    Kinoshita, Y.5
  • 5
    • 0032915278 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease
    • DOI 10.1046/j.1365-2036.1999.00438.x
    • Dekkers CPM, Beker JA, Th jodleifsson B et al. Double-blind, placebocontrolled comparison of rabeprazole 20 mg vs omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. Aliment Pharmacol Th er 1999;13:49-57. (Pubitemid 29048056)
    • (1999) Alimentary Pharmacology and Therapeutics , vol.13 , Issue.1 , pp. 49-57
    • Dekkers, C.P.M.1    Beker, J.A.2    Thjodleifsson, B.3    Gabryelewicz, A.4    Bell, N.E.5    Humphries, T.J.6
  • 8
    • 0033785204 scopus 로고    scopus 로고
    • Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: A randomized controlled trial
    • Kahrilas PJ, Falk GW, Johnson DA et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Aliment Pharmacol Th er 2000;14:1249-58.
    • (2000) Aliment Pharmacol Th Er , vol.14 , pp. 1249-1258
    • Kahrilas, P.J.1    Falk, G.W.2    Johnson, D.A.3
  • 9
    • 39049183768 scopus 로고    scopus 로고
    • Treatment of proton pump inhibitor - Resistant patients with gastroesophageal reflux disease
    • Kinoshita Y, Kazumori H, Ishihara S. Treatment of proton pump inhibitor - resistant patients with gastroesophageal reflux disease. J Gastroenterol 2006;41:286-7.
    • (2006) J Gastroenterol , vol.41 , pp. 286-287
    • Kinoshita, Y.1    Kazumori, H.2    Ishihara, S.3
  • 10
    • 22844451154 scopus 로고    scopus 로고
    • Systematic review: Proton-pump inhibitor failure in gastro-oesophageal reflux disease - Where next?
    • DOI 10.1111/j.1365-2036.2005.02531.x
    • Fass R, Shapiro M, Dekel R et al. Systematic review: systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease- where next? Aliment Pharmacol Th er 2005;22:79-94. (Pubitemid 41039696)
    • (2005) Alimentary Pharmacology and Therapeutics , vol.22 , Issue.2 , pp. 79-94
    • Fass, R.1    Shapiro, M.2    Dekel, R.3    Sewell, J.4
  • 11
    • 58849095408 scopus 로고    scopus 로고
    • Management of heartburn not responding to proton pump inhibitors
    • Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009;58:295-309.
    • (2009) Gut , vol.58 , pp. 295-309
    • Fass, R.1    Sifrim, D.2
  • 12
    • 0027858321 scopus 로고
    • Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases
    • Dimenas E. Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases. Scand J Gastroenterol 1993;28 (Suppl 199):18-21. (Pubitemid 24084823)
    • (1993) Scandinavian Journal of Gastroenterology, Supplement , vol.28 , Issue.199 , pp. 18-21
    • Dimenas, E.1
  • 13
    • 33746709974 scopus 로고    scopus 로고
    • Th e Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus
    • Vakil N, van Zanten S, Kahrilas P et al. Th e Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1900-1920
    • Vakil, N.1    Van Zanten, S.2    Kahrilas, P.3
  • 15
    • 13744261420 scopus 로고    scopus 로고
    • Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
    • DOI 10.1111/j.1572-0241.2005.41217.x
    • DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005;100:190-200. (Pubitemid 41623288)
    • (2005) American Journal of Gastroenterology , vol.100 , Issue.1 , pp. 190-200
    • DeVault, K.R.1    Castell, D.O.2
  • 17
    • 0036188029 scopus 로고    scopus 로고
    • Onset of symptom relief with rabeprazole: A community-based, open-label assessment of patients with erosive oesophagitis
    • DOI 10.1046/j.1365-2036.2002.01181.x
    • Robinson M, Fitzgerald S, Hegedus R et al. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Th er 2002;16:445-54. (Pubitemid 34214523)
    • (2002) Alimentary Pharmacology and Therapeutics , vol.16 , Issue.3 , pp. 445-454
    • Robinson, M.1    Fitzgerald, S.2    Hegedus, R.3    Murthy, A.4    Jokubaitis, L.5
  • 18
    • 0036191747 scopus 로고    scopus 로고
    • A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease
    • DOI 10.1046/j.1365-2036.2002.01207.x
    • Holtmann G, Bytzer P, Metz M et al. A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. Aliment Pharmacol Th er 2002;16 : 479-85. (Pubitemid 34214527)
    • (2002) Alimentary Pharmacology and Therapeutics , vol.16 , Issue.3 , pp. 479-485
    • Holtmann, G.1    Bytzer, P.2    Metz, M.3    Loeffler, V.4    Blum, A.L.5
  • 19
    • 9944234997 scopus 로고    scopus 로고
    • Review article: Relief of symptoms in gastric acid-related diseases - Correlation with acid suppression in rabeprazole treatment
    • Miner P. Relief of symptoms in gastric acid-related diseases- correlation with acid suppression in rabeprazole treatment. Aliment Pharmacol Th er 2004;20 (Suppl. 6):20-9. (Pubitemid 39593284)
    • (2004) Alimentary Pharmacology and Therapeutics, Supplement , vol.20 , Issue.6 , pp. 20-29
    • Miner, P.1
  • 20
    • 1642574277 scopus 로고    scopus 로고
    • Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression
    • DOI 10.1046/j.1365-2036.2003.01821.x
    • Shimatani T, Inoue M, Kuroiwa T et al. Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression. Aliment Pharmacol Th er 2004;19:113-22. (Pubitemid 38125644)
    • (2004) Alimentary Pharmacology and Therapeutics , vol.19 , Issue.1 , pp. 113-122
    • Shimatani, T.1    Inoue, M.2    Kuroiwa, T.3    Horikawa, Y.4
  • 22
    • 33748921737 scopus 로고    scopus 로고
    • Acid-suppressive effects of rabeprazole: Comparing 10 mg and 20 mg twice daily in Japanese Helicobacter pylori-negative and -positive CYP2C19 extensive metabolisers
    • DOI 10.1016/j.dld.2006.06.002, PII S1590865806002416
    • Shimatani T, Moriwaki M, Xu J et al. Acid-suppressive eff ects of rabeprazole: comparing 10 and 20 mg twice daily in Japanese Helicobacter pylori-negative and-positive CYP2C19 extensive metabolisers. Dig Liver Dis 2006;38:802-8. (Pubitemid 44430926)
    • (2006) Digestive and Liver Disease , vol.38 , Issue.11 , pp. 802-808
    • Shimatani, T.1    Moriwaki, M.2    Xu, J.3    Tazuma, S.4    Inoue, M.5
  • 23
    • 0034518996 scopus 로고    scopus 로고
    • Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastro-oesophageal reflux disease
    • DOI 10.1080/003655200453566
    • Delchier JC, Cohen G, Humphries TJ. Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastro-oesophageal reflux disease. Scand J Gastroenterol 2000;35:1245-50. (Pubitemid 32051636)
    • (2000) Scandinavian Journal of Gastroenterology , vol.35 , Issue.12 , pp. 1245-1250
    • Delchier, J.-C.1    Cohen, G.2    Humphries, T.J.3
  • 24
    • 33750466912 scopus 로고    scopus 로고
    • A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: A randomized three-way crossover study
    • DOI 10.1111/j.1365-2036.2006.03140.x
    • Miki M, Adachi K, Azumi T et al. A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study. Aliment Pharmacol Th er 2006;24:1445-51. (Pubitemid 44657121)
    • (2006) Alimentary Pharmacology and Therapeutics , vol.24 , Issue.10 , pp. 1445-1451
    • Miki, M.1    Adachi, K.2    Azumi, T.3    Koshino, K.4    Furuta, K.5    Kinoshita, Y.6
  • 25
    • 10344259101 scopus 로고    scopus 로고
    • Dose this woman have osteoporosis?
    • Amanda DG, Cathleen SCE, Lori B et al. Dose this woman have osteoporosis? JAMA 2004;292:2890-900.
    • (2004) JAMA , vol.292 , pp. 2890-2900
    • Amanda, D.G.1    Cathleen, S.C.E.2    Lori, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.